Document is current
Any future updates will be listed below
-
Authors
Tillett, Bree J.
Dwiyanto, Jacky
Secombe, Kate R.
George, Thomas https://orcid.org/0009-0008-6384-9913
Zhang, Vivian
Anderson, Dovile https://orcid.org/0000-0003-0284-471X
Duggan, Emily
Giri, Rabina https://orcid.org/0000-0002-6712-6076
Loo, Dorothy
Stoll, Thomas https://orcid.org/0000-0002-6275-3433
Morrison, Mark https://orcid.org/0000-0001-9257-9133
Begun, Jakob https://orcid.org/0000-0001-5256-7672
Hill, Michelle M.
Gurzov, Esteban N. https://orcid.org/0000-0003-4642-0273
Bell, Kirstine J.
Saad, Sonia
Barlow, Christopher K. https://orcid.org/0000-0001-9309-2829
Creek, Darren J. https://orcid.org/0000-0001-7497-7082
Chong, Chun Wie https://orcid.org/0000-0002-6881-8883
Mariño, Eliana https://orcid.org/0000-0001-5371-8778
Hamilton-Williams, Emma E. https://orcid.org/0000-0003-4892-3691
- License Information
-
More Information
Article History
Received: 17 April 2024
Accepted: 14 March 2025
First Online: 25 March 2025
Competing interests
: E.M. is an inventor on a patent WO2018027274A1 submitted by Monash University that covers methods and compositions for metabolites for the treatment and prevention of autoimmune disease related to this paper, and is the founder of ImmunoBiota Therapeutics Pty Ltd. All other authors declare no competing interests.
